139 related articles for article (PubMed ID: 36688767)
1. Lyophilized cell-free supernatants of the oral probiotics Streptococcus salivarius M18 and Streptococcus salivarius K12 show promises for milk safety.
Karaçam S; Tunçer S
Lett Appl Microbiol; 2023 Jan; 76(1):. PubMed ID: 36688767
[TBL] [Abstract][Full Text] [Related]
2. Oral Probiotics, Streptococcus salivarius K12 and M18, Suppress the Release of Volatile Sulfur Compounds and a Virulent Protease from Oral Bacteria: An In-Vitro Study.
Park JA; Lee GR; Lee JY; Jin BH
Oral Health Prev Dent; 2023 Aug; 21():259-270. PubMed ID: 37724895
[TBL] [Abstract][Full Text] [Related]
3. Cell-free supernatant of Streptococcus salivarius M18 impairs the pathogenic properties of Pseudomonas aeruginosa and Klebsiella pneumonia.
Tunçer S; Karaçam S
Arch Microbiol; 2020 Dec; 202(10):2825-2840. PubMed ID: 32747998
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of Streptococcus salivarius K12 and M18 on halitosis in vitro.
Yoo HJ; Jwa SK; Kim DH; Ji YJ
Clin Exp Dent Res; 2020 Apr; 6(2):207-214. PubMed ID: 32250565
[TBL] [Abstract][Full Text] [Related]
5. Exploiting the Acidic Extracellular pH: Evaluation of Streptococcus salivarius M18 Postbiotics to Target Cancer Cells.
Karaçam S; Tunçer S
Probiotics Antimicrob Proteins; 2022 Dec; 14(6):995-1011. PubMed ID: 34080175
[TBL] [Abstract][Full Text] [Related]
6. Safety assessment of
Hale JDF; Jain R; Wescombe PA; Burton JP; Simon RR; Tagg JR
Benef Microbes; 2022 Feb; 13(1):47-60. PubMed ID: 35098909
[TBL] [Abstract][Full Text] [Related]
7. A concerted probiotic activity to inhibit periodontitis-associated bacteria.
Jansen PM; Abdelbary MMH; Conrads G
PLoS One; 2021; 16(3):e0248308. PubMed ID: 33667279
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial effect of probiotic bacteriocins on
Reichardt E; Shyp V; Alig L; Verna C; Kulik EM; Bornstein MM
J Oral Microbiol; 2024; 16(1):2304971. PubMed ID: 38288293
[TBL] [Abstract][Full Text] [Related]
9. Streptococcus salivarius inhibits immune activation by periodontal disease pathogens.
MacDonald KW; Chanyi RM; Macklaim JM; Cadieux PA; Reid G; Burton JP
BMC Oral Health; 2021 May; 21(1):245. PubMed ID: 33962608
[TBL] [Abstract][Full Text] [Related]
10. Probiotic
Wang Y; Li J; Zhang H; Zheng X; Wang J; Jia X; Peng X; Xie Q; Zou J; Zheng L; Li J; Zhou X; Xu X
Front Immunol; 2021; 12():684824. PubMed ID: 34149727
[TBL] [Abstract][Full Text] [Related]
11. Interferon Gamma Response in Human Saliva Following Exposure to the Oral Probiotic Streptococcus salivarius BLIS K12.
Laws GA; Harold LK; Tagg JR; Hale JDF
Probiotics Antimicrob Proteins; 2024 Feb; 16(1):93-98. PubMed ID: 36477439
[TBL] [Abstract][Full Text] [Related]
12. Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review.
Zupancic K; Kriksic V; Kovacevic I; Kovacevic D
Probiotics Antimicrob Proteins; 2017 Jun; 9(2):102-110. PubMed ID: 28236205
[TBL] [Abstract][Full Text] [Related]
13. Effect of Streptococcus salivarius K12 on the in vitro growth of Candida albicans and its protective effect in an oral candidiasis model.
Ishijima SA; Hayama K; Burton JP; Reid G; Okada M; Matsushita Y; Abe S
Appl Environ Microbiol; 2012 Apr; 78(7):2190-9. PubMed ID: 22267663
[TBL] [Abstract][Full Text] [Related]
14. Multi-Strain Probiotic Supplementation with a Product Containing Human-Native
Cernioglo K; Kalanetra KM; Meier A; Lewis ZT; Underwood MA; Mills DA; Smilowitz JT
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959944
[No Abstract] [Full Text] [Related]
15. In vitro Inhibition of Clinical Isolates of Otitis Media Pathogens by the Probiotic Streptococcus salivarius BLIS K12.
Chen TY; Hale JDF; Tagg JR; Jain R; Voss AL; Mills N; Best EJ; Stevenson DS; Bird PA; Walls T
Probiotics Antimicrob Proteins; 2021 Jun; 13(3):734-738. PubMed ID: 33179212
[TBL] [Abstract][Full Text] [Related]
16. Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebo-controlled trial.
Burton JP; Drummond BK; Chilcott CN; Tagg JR; Thomson WM; Hale JDF; Wescombe PA
J Med Microbiol; 2013 Jun; 62(Pt 6):875-884. PubMed ID: 23449874
[TBL] [Abstract][Full Text] [Related]
17. Extended Safety Data for the Oral Cavity Probiotic Streptococcus salivarius K12.
Burton JP; Chilcott CN; Wescombe PA; Tagg JR
Probiotics Antimicrob Proteins; 2010 Oct; 2(3):135-44. PubMed ID: 26781236
[TBL] [Abstract][Full Text] [Related]
18. Investigation of Streptococcus salivarius-mediated inhibition of pneumococcal adherence to pharyngeal epithelial cells.
Manning J; Dunne EM; Wescombe PA; Hale JD; Mulholland EK; Tagg JR; Robins-Browne RM; Satzke C
BMC Microbiol; 2016 Sep; 16(1):225. PubMed ID: 27681377
[TBL] [Abstract][Full Text] [Related]
19. Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics.
Burton JP; Wescombe PA; Macklaim JM; Chai MH; Macdonald K; Hale JD; Tagg J; Reid G; Gloor GB; Cadieux PA
PLoS One; 2013; 8(6):e65991. PubMed ID: 23785463
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial and Antibiofilm Activity of the Probiotic Strain
Stašková A; Sondorová M; Nemcová R; Kačírová J; Maďar M
Antibiotics (Basel); 2021 Jun; 10(7):. PubMed ID: 34209988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
